E1684: ECOG E1684 Trial
In hdbayes: Bayesian Analysis of Generalized Linear Models with Historical Data
E1684 R Documentation
ECOG E1684 Trial
Description
A data set from the ECOG E1684 trial comparing the high-dose interferon alfa-2b (IFN)
therapy with the observation in resected high-risk melanoma patients. The study results
were described in Kirkwood et al. (1996) doi:10.1200/JCO.1996.14.1.7.
Usage
E1684
Format
A data frame with 262 rows and 8 variables:
- failtime
time to relapse in years
- failcens
censoring indicator for time to relapse, 0 = did not relapse, 1 = relapsed
- survtime
time to death in years
- survcens
censoring indicator for time to death, 0 = alive, 1 = dead
- treatment
treatment indicator, 0 = observation, 1 = high-dose IFN
- sex
gender indicator, 0 = male, 1 = female
- age
patient age in years
- node_bin
indicator for having more than one cancerous lymph node,
0 = with one or no cancerous lymph nodes,
1 = with more than one cancerous lymph node
References
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., and Blum, R. H. (1996). Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684. Journal of Clinical Oncology, 14(1), 7–17.
hdbayes documentation built on Sept. 11, 2024, 5:34 p.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| E1684 | R Documentation |
ECOG E1684 Trial
Description
A data set from the ECOG E1684 trial comparing the high-dose interferon alfa-2b (IFN) therapy with the observation in resected high-risk melanoma patients. The study results were described in Kirkwood et al. (1996) doi:10.1200/JCO.1996.14.1.7.
Usage
E1684
Format
A data frame with 262 rows and 8 variables:
- failtime
time to relapse in years
- failcens
censoring indicator for time to relapse, 0 = did not relapse, 1 = relapsed
- survtime
time to death in years
- survcens
censoring indicator for time to death, 0 = alive, 1 = dead
- treatment
treatment indicator, 0 = observation, 1 = high-dose IFN
- sex
gender indicator, 0 = male, 1 = female
- age
patient age in years
- node_bin
indicator for having more than one cancerous lymph node, 0 = with one or no cancerous lymph nodes, 1 = with more than one cancerous lymph node
References
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., and Blum, R. H. (1996). Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684. Journal of Clinical Oncology, 14(1), 7–17.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.